[96a5a0]: / output / allTrials / identified / NCT00089427_identified.json

Download this file

498 lines (498 with data), 21.9 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
{
"info": {
"nct_id": "NCT00089427",
"official_title": "Phase I Study of Convection Enhanced Delivery (CED) of IL13-PE38QQR Infusion After Resection Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma",
"inclusion_criteria": "* Patients must be ≥18 years old.\n* Patients must have undergone a gross total resection of the solid contrast-enhancing lesion(s) > 1.0 cm in diameter.\n* Patients must be able to have catheters placed within 14 days of tumor resection (including a planned Gross Total Resection following an initial biopsy or subtotal resection)\n* Patients must have histopathologic confirmation of malignant glioma from resection specimen. Diagnosis must be consistent with either GBM, AA, or malignant mixed OA.\n* Patients must be in adequate general condition and meet the following criteria:\n* a. Karnofsky Performance Scale score ≥ 70\n* b. Adequate hematologic status:\n\n * Absolute neutrophil count ≥ 1,500/mm³\n * Hemoglobin ≥ 10 gm/dL\n * Platelets ≥ 100,000/mm³\n * PT & aPTT within institutional limits of normal\n* Female patients must not be pregnant or breast-feeding.\n* Patients must practice an effective method of birth control during the study and for 60 days beyond the last day of infusion.\n* Patients must understand the investigational nature of this study and its potential risks and benefits, and sign an approved written informed consent prior to performance of any study-specific procedure.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Patients with residual contrast-enhancing tumor crossing the midline, multifocal tumor not amenable to gross total resection or non-parenchymal tumor dissemination (e.g., subependymal or leptomeningeal).\n* Patients with clinically significant increased ICP (e.g., impending herniation), uncontrolled seizures or requirement for immediate palliative treatment.\n* Patients who have received any prior anti-tumor treatment (other than corticosteroids) including any investigational agents.\n* Patients with any metallic prosthesis that would prevent MRI and/or MRS scanning procedures of the brain.\n* Patients unwilling or unable to follow protocol requirements.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients must be ≥18 years old.",
"criterions": [
{
"exact_snippets": "Patients must be ≥18 years old.",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Patients must have undergone a gross total resection of the solid contrast-enhancing lesion(s) > 1.0 cm in diameter.",
"criterions": [
{
"exact_snippets": "undergone a gross total resection of the solid contrast-enhancing lesion(s)",
"criterion": "gross total resection of solid contrast-enhancing lesion(s)",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
},
{
"exact_snippets": "lesion(s) > 1.0 cm in diameter",
"criterion": "lesion size",
"requirements": [
{
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 1.0,
"unit": "cm"
}
}
]
}
]
},
{
"line": "* Patients must be able to have catheters placed within 14 days of tumor resection (including a planned Gross Total Resection following an initial biopsy or subtotal resection)",
"criterions": [
{
"exact_snippets": "Patients must be able to have catheters placed",
"criterion": "catheter placement ability",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "within 14 days of tumor resection",
"criterion": "catheter placement timing",
"requirements": [
{
"requirement_type": "timing",
"expected_value": {
"operator": "<=",
"value": 14,
"unit": "days"
}
}
]
}
]
},
{
"line": "* Patients must have histopathologic confirmation of malignant glioma from resection specimen. Diagnosis must be consistent with either GBM, AA, or malignant mixed OA.",
"criterions": [
{
"exact_snippets": "histopathologic confirmation of malignant glioma",
"criterion": "malignant glioma",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": true
}
]
},
{
"exact_snippets": "Diagnosis must be consistent with either GBM, AA, or malignant mixed OA",
"criterion": "diagnosis consistency",
"requirements": [
{
"requirement_type": "consistency",
"expected_value": [
"GBM",
"AA",
"malignant mixed OA"
]
}
]
}
]
},
{
"line": "* Patients must be in adequate general condition and meet the following criteria:",
"criterions": [
{
"exact_snippets": "adequate general condition",
"criterion": "general condition",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* a. Karnofsky Performance Scale score ≥ 70",
"criterions": [
{
"exact_snippets": "Karnofsky Performance Scale score ≥ 70",
"criterion": "Karnofsky Performance Scale score",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"operator": ">=",
"value": 70,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* b. Adequate hematologic status:",
"criterions": [
{
"exact_snippets": "Adequate hematologic status",
"criterion": "hematologic status",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* Absolute neutrophil count ≥ 1,500/mm³",
"criterions": [
{
"exact_snippets": "Absolute neutrophil count ≥ 1,500/mm³",
"criterion": "absolute neutrophil count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "mm³"
}
}
]
}
]
},
{
"line": "* Hemoglobin ≥ 10 gm/dL",
"criterions": [
{
"exact_snippets": "Hemoglobin ≥ 10 gm/dL",
"criterion": "hemoglobin level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 10,
"unit": "gm/dL"
}
}
]
}
]
},
{
"line": "* Platelets ≥ 100,000/mm³",
"criterions": [
{
"exact_snippets": "Platelets ≥ 100,000/mm³",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "mm³"
}
}
]
}
]
},
{
"line": "* PT & aPTT within institutional limits of normal",
"criterions": [
{
"exact_snippets": "PT ... within institutional limits of normal",
"criterion": "PT",
"requirements": [
{
"requirement_type": "range",
"expected_value": "within institutional limits of normal"
}
]
},
{
"exact_snippets": "aPTT within institutional limits of normal",
"criterion": "aPTT",
"requirements": [
{
"requirement_type": "range",
"expected_value": "within institutional limits of normal"
}
]
}
]
},
{
"line": "* Female patients must not be pregnant or breast-feeding.",
"criterions": [
{
"exact_snippets": "Female patients must not be pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Female patients must not be ... breast-feeding",
"criterion": "breast-feeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients must practice an effective method of birth control during the study and for 60 days beyond the last day of infusion.",
"criterions": [
{
"exact_snippets": "Patients must practice an effective method of birth control",
"criterion": "birth control",
"requirements": [
{
"requirement_type": "practice",
"expected_value": true
}
]
},
{
"exact_snippets": "during the study and for 60 days beyond the last day of infusion",
"criterion": "duration of birth control",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "during the study and for 60 days beyond the last day of infusion"
}
]
}
]
},
{
"line": "* Patients must understand the investigational nature of this study and its potential risks and benefits, and sign an approved written informed consent prior to performance of any study-specific procedure.",
"criterions": [
{
"exact_snippets": "Patients must understand the investigational nature of this study and its potential risks and benefits",
"criterion": "understanding of study nature and risks/benefits",
"requirements": [
{
"requirement_type": "understanding",
"expected_value": true
}
]
},
{
"exact_snippets": "sign an approved written informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Patients with residual contrast-enhancing tumor crossing the midline, multifocal tumor not amenable to gross total resection or non-parenchymal tumor dissemination (e.g., subependymal or leptomeningeal).",
"criterions": [
{
"exact_snippets": "residual contrast-enhancing tumor crossing the midline",
"criterion": "residual contrast-enhancing tumor crossing the midline",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "multifocal tumor not amenable to gross total resection",
"criterion": "multifocal tumor",
"requirements": [
{
"requirement_type": "amenability to gross total resection",
"expected_value": false
}
]
},
{
"exact_snippets": "non-parenchymal tumor dissemination (e.g., subependymal or leptomeningeal)",
"criterion": "non-parenchymal tumor dissemination",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with clinically significant increased ICP (e.g., impending herniation), uncontrolled seizures or requirement for immediate palliative treatment.",
"criterions": [
{
"exact_snippets": "clinically significant increased ICP",
"criterion": "increased intracranial pressure (ICP)",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "clinically significant"
}
]
},
{
"exact_snippets": "uncontrolled seizures",
"criterion": "seizures",
"requirements": [
{
"requirement_type": "control",
"expected_value": "uncontrolled"
}
]
},
{
"exact_snippets": "requirement for immediate palliative treatment",
"criterion": "palliative treatment",
"requirements": [
{
"requirement_type": "urgency",
"expected_value": "immediate"
}
]
}
]
},
{
"line": "* Patients who have received any prior anti-tumor treatment (other than corticosteroids) including any investigational agents.",
"criterions": [
{
"exact_snippets": "Patients who have received any prior anti-tumor treatment (other than corticosteroids)",
"criterion": "prior anti-tumor treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "including any investigational agents",
"criterion": "prior investigational agents",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with any metallic prosthesis that would prevent MRI and/or MRS scanning procedures of the brain.",
"criterions": [
{
"exact_snippets": "any metallic prosthesis that would prevent MRI and/or MRS scanning procedures of the brain",
"criterion": "metallic prosthesis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients unwilling or unable to follow protocol requirements.",
"criterions": [
{
"exact_snippets": "Patients unwilling ... to follow protocol requirements.",
"criterion": "willingness to follow protocol requirements",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
},
{
"exact_snippets": "Patients ... unable to follow protocol requirements.",
"criterion": "ability to follow protocol requirements",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}